drugset / Trial / NCT06704113

Meloxicam Versus Ibuprofen for Pain Control After Third Molar Exodontia in Adult Patients

NCT06704113

Phase 4 Not yet recruiting 68 enrolled Universidad Austral de Chile
RandomizedParallel-groupSingle-blindTreatment

Summary

Third molar extraction is a common dental procedure, offently related with pain and swelling. The purpose of this study is to evaluate if Meloxicam has a better effect relieving pain after the extraction than Ibuprofen, one of the most common pain relieving drugs administered after this procedure.

Timeline

Start
2024-12-15
Primary completion
2025-01-15
Completion
2025-01-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 400 mg
Comparator Meloxicam Small molecule 7.5 mg